12 Health Care Stocks Moving In Tuesday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Tuesday's after-market session, several health care stocks showed significant movement. FibroBiologics, Sonnet BioTherapeutics, GlucoTrack, Clene, Larimar Therapeutics, and BiomX were among the gainers, with FibroBiologics leading with a 25% increase. On the downside, QuidelOrtho, Alzamend Neuro, Assure Hldgs, Adial Pharmaceuticals, NeuroOne Medical Tech, and NanoString Technologies experienced declines, with QuidelOrtho dropping 28.2% after its Q4 earnings release.
February 13, 2024 | 9:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
QuidelOrtho's stock declined by 28.2% to $47.9 following the release of its Q4 earnings.
The significant drop in QuidelOrtho's stock price post-Q4 earnings suggests the results did not meet market expectations, leading to negative investor sentiment.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 95
POSITIVE IMPACT
FibroBiologics saw a significant increase of 25% to $17.43 in Tuesday's after-market session.
The substantial increase in FibroBiologics' stock price indicates strong investor confidence, potentially due to positive developments or expectations.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90